tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Legend Biotech falls -10.5%
PremiumThe FlyLegend Biotech falls -10.5%
11d ago
Legend Biotech Announces Preliminary Q4 2025 CARVYKTI Sales of Approximately $555 Million
Premium
Company Announcements
Legend Biotech Announces Preliminary Q4 2025 CARVYKTI Sales of Approximately $555 Million
11d ago
FDA draft guidance favorable for Legend Biotech, says RBC Capital
Premium
The Fly
FDA draft guidance favorable for Legend Biotech, says RBC Capital
11d ago
Legend Biotech price target lowered to $74 from $75 at Cantor Fitzgerald
PremiumThe FlyLegend Biotech price target lowered to $74 from $75 at Cantor Fitzgerald
2M ago
Legend Biotech management to meet with  Cantor Fitzgerald
Premium
The Fly
Legend Biotech management to meet with Cantor Fitzgerald
2M ago
Legend Biotech price target lowered to $50 from $83 at Morgan Stanley
Premium
The Fly
Legend Biotech price target lowered to $50 from $83 at Morgan Stanley
2M ago
Legend Biotech Unveils Promising CARVYKTI® Data at ASH 2025
PremiumCompany AnnouncementsLegend Biotech Unveils Promising CARVYKTI® Data at ASH 2025
2M ago
Legend Biotech price target lowered to $48 from $54 at UBS
Premium
The Fly
Legend Biotech price target lowered to $48 from $54 at UBS
2M ago
Legend Biotech highlights new CARVYKTI data in RRMM
Premium
The Fly
Legend Biotech highlights new CARVYKTI data in RRMM
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100